Midlands Partnership NHS Foundation Trust (MPFT), NHS Digital and CLEO Systems have collaborated in a successful first-of-type pilot in secondary care, to implement the electronic prescription solution, CLEO SOLO EPS. The deployment is now delivering key efficiency benefits, digitising the process of sending prescriptions to pharmacies and enabling improved patient choice.
CLEO SOLO EPS is an instant electronic prescribing solution which enables quick, seamless, clinically safe prescribing, achieving accreditation from NHS Digital in June 2022. It can be used in a wide range of outpatient secondary care and community settings, enabling patients’ prescriptions to be entered and sent electronically to a nominated community pharmacy of a patient’s choice. The pilot at MPFT has resulted in significant operational efficiency benefits and improvements from a clinical safety perspective, including a reduction in prescribing errors, cutting travel times, enhanced sustainability, as well as generally making life easier for clinicians and patients alike.
The pilot aligns with the NHS Long Term Plan, which focuses on the use of EPS within primary care, as well as the Trust’s strategy for local IMT digital strategy and medicines optimisation transformation. The results from the pilot were so encouraging that MPFT is now set to roll out more widely across the Trust.
Read our full case study here